Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Evaluation of Bevacizumab, in Combination With Docetaxel and Cyclophosphamide in the Adjuvant Treatment of Patients With HER 2 Negative Breast Cancer

NCT00911716 is registered in ClinicalTrials.gov with Cancer Trials Ireland as lead sponsor.

NCT NCT00911716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00911716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Evaluation of Bevacizumab, in Combination With Docetaxel and Cyclophosphamide in the Adjuvant Treatment of Patients With HER 2 Negative Breast Cancer
Lead sponsor
Cancer Trials Ireland
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2008
Completion date
September 30, 2015
Enrollment
106 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer